Cognis Reports Strong Growth for Nutrition Business

Nutrition & Health achieved total sales of 182 million euros, a 6.0 percent rise. This was largely attributable to the growth of major product lines for the food ingredients business segment and the Vitamin E business.

27/08/08 In the first six months of 2008, global specialty chemicals supplier Cognis increased the net sales of its core businesses by 7.0 percent to 1.533 billion euros compared with the same period in 2007. On an organic basis, sales grew by 12.0 percent. All three strategic business units that focus on the innovation-driven wellness and sustainability markets – Care Chemicals, Nutrition & Health and Functional Products – contributed to the sales growth. The company also benefited from various initiatives to optimize its cost structures and further improve its efficiency, and was able to partially compensate its increased raw material costs by increasing its prices.

Nutrition & Health achieved total sales of 182 million euros, a 6.0 percent rise (organic sales growth of 8.6 percent). This was largely attributable to the growth of major product lines for the food ingredients business segment and the Vitamin E business.

As a whole the operating result of the core businesses (Adjusted EBITDA) was at 176 million euros (down 5.1 percent) due to a massive rise in raw material, transportation, and energy costs as well as unfavorable exchange rates. On an organic basis, the operating result was down 2.4 percent (excluding foreign currency effects and the sale of Functional Products’ G-Cure business).

Return on sales (Adjusted EBITDA as a percentage of sales) meanwhile stood at  11.5 percent. Earnings before interest and taxes (EBIT) of core businesses were down 5 million euros to 103 million euros due to the increase in operating costs mentioned above. Net profit before exceptional items (including discontinued operations) decreased by 20 million euros to 19 million due to tax effects. However, net profit including exceptional items was 28 million euros above last year which was affected by one-time effects as a result of the company’s refinancing transactions.

Comments Cognis CEO Antonio Trius: “In spite of the tough general market conditions, all our core business areas strengthened their position and recorded increased sales. Our successful efforts to optimize our processing and manufacturing costs, and more especially the sale of our Pulcra and Oleochemicals businesses, represent major steps forward for Cognis in terms of its strategic direction and prospects for further profitable growth.”

 “Cognis continues to improve its efficiency, and sees the necessity to further increase its prices in the light of high raw material costs and the weak US dollar,” says Antonio Trius. “Concentrating on highly innovative, natural-based solutions for markets driven by the global wellness and sustainability trends will help us to add further value to our company in 2008.”